PGC-1 deregulation is linked with the development and progression of PD through increasing sensitivity of DNs to the effect of neurotoxins like MPTP
It does not have the formal approvals, large safety trials, or standardized manufacturing controls that approved drugs have
Common side effects for both medications can include: Gastrointestinal Symptoms: Nausea, vomiting, diarrhea, and stomach discomfort are relatively common side effects when starting GLP-1 RAs
If your body is unable to produce sufficient glutathione naturally after you stop supplementation: You may experience increased oxidative damage, which is linked to ageing, inflammation, and chronic diseases
Ethical Statement: Animal studies were carried out according to the institutional animal welfare guidelines and approved by the Experimental Animal Center of Jilin University (Ethics Number SY202107301)
This effect has also been studied in animals and in patients undergoing alcohol and opiate withdrawal treatment